Parkside Financial Bank & Trust’s 2seventy bio TSVT Stock Holding History

Parkside Financial Bank & Trust’s Portfolio TSVT Stock Details TSVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33	Closed	-$164	–	2996
2025 Q1	$164	Hold	33	–	–	﹤0.01%	2696
2024 Q4	$98	Hold	33	–	–	﹤0.01%	2116
2024 Q3	$156	Hold	33	–	–	﹤0.01%	2051
2024 Q2	$128	Hold	33	–	–	﹤0.01%	2005
2024 Q1	$177	Hold	33	–	–	﹤0.01%	1960
2023 Q4	$141	Hold	33	–	–	﹤0.01%	2004
2023 Q3	$130	Hold	33	–	–	﹤0.01%	2010
2023 Q2	$334	Hold	33	–	–	﹤0.01%	1928
2023 Q1	$337	Hold	33	–	–	﹤0.01%	1929
2022 Q4	$309	Hold	33	–	–	﹤0.01%	1944
2022 Q3	$0	Hold	33	–	–	﹤0.01%	1955
2022 Q2	$0	Hold	33	–	–	﹤0.01%	1958
2022 Q1	$1K	Hold	33	–	–	﹤0.01%	1780
2021 Q4	$1K	Buy	+33	New	+$1.03K	﹤0.01%	1763

Other funds holding TSVT

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Parkside Financial Bank & Trust's TSVT Position: Q2 2025 in Review

Parkside Financial Bank & Trust sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 33 shares — an estimated $164 sold.

Parkside Financial Bank & Trust first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $1K in Q1 2022. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

Parkside Financial Bank & Trust reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
Parkside Financial Bank & Trust sold 33 2seventy bio shares in Q2 2025, an estimated $164.
Parkside Financial Bank & Trust first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
Parkside Financial Bank & Trust's 2seventy bio position peaked at $1K in Q1 2022.
2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2025, filed 7 Aug 2025.